Sweeping clinical trials in which thousands of patients are studied for years at a stretch have long been the Holy Grail of medical research—especially when funded by the federal government.

But in the era of personalized medicine, where care can be tailored to a person’s genetic make-up and doctors analyze a patient’s DNA to figure out treatments, big trials are falling out of favor.

Instead,...